New hope for ankylosing spondylitis patients in korea
NCT ID NCT06905288
First seen Feb 26, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This study is for people with ankylosing spondylitis (a type of arthritis that affects the spine) who have never used certain biologic drugs. It will test how well secukinumab works and how safe it is. About 70 participants will be observed over time to see if their symptoms and inflammation improve.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Novartis Investigative Site
RECRUITINGJinju, Gyeongsangnam-do, 52727, South Korea
-
Novartis Investigative Site
RECRUITINGBusan, 49201, South Korea
Conditions
Explore the condition pages connected to this study.